Pathogenesis of chronic hepatitis C: immunological features of hepatic injury and viral persistence.
about
Direct-acting antivirals for chronic hepatitis CHuman butyrate-induced transcript 1 interacts with hepatitis C virus NS5A and regulates viral replicationHuman VAP-B is involved in hepatitis C virus replication through interaction with NS5A and NS5BExpression of hepatitis C virus proteins induces distinct membrane alterations including a candidate viral replication complexSimultaneous assessment of cytotoxic T lymphocyte responses against multiple viral infections by combined usage of optimal epitope matrices, anti- CD3 mAb T-cell expansion and "RecycleSpot"Hepatitis C virus core protein suppresses NF-kappaB activation and cyclooxygenase-2 expression by direct interaction with IkappaB kinase betaDNA microarray analysis of chimpanzee liver during acute resolving hepatitis C virus infection.Mapping B-cell epitopes of hepatitis C virus E2 glycoprotein using human monoclonal antibodies from phage display librariesDifferent Levels of T-Cell Receptor Triggering Induce Distinct Functions in Hepatitis B and Hepatitis C Virus-Specific Human CD4+ T-Cell ClonesLongitudinal Evaluation of the Structure of Replicating and Circulating Hepatitis C Virus Quasispecies in Nonprogressive Chronic Hepatitis C PatientsCharacterization of hepatitis C virus quasispecies by matrix-assisted laser desorption ionization-time of flight (mass spectrometry) mutation detection.Effect of bottlenecking on evolution of the nonstructural protein 3 gene of hepatitis C virus during sexually transmitted acute resolving infectionHepatitis C virus induces toll-like receptor 4 expression, leading to enhanced production of beta interferon and interleukin-6Diverging Effects of Human Recombinant Anti-Hepatitis C Virus (HCV) Antibody Fragments Derived from a Single Patient on the Infectivity of a Vesicular Stomatitis Virus/HCV PseudotypeEstablishment of B-cell lymphoma cell lines persistently infected with hepatitis C virus in vivo and in vitro: the apoptotic effects of virus infection.Oligomerization of Hepatitis C Virus Core Protein Is Crucial for Interaction with the Cytoplasmic Domain of E1 Envelope ProteinSecond infection with a different hepatitis C virus genotype in a intravenous drug user during interferon therapyVirological analysis and phenotypic characterization of peripheral blood lymphocytes of hepatitis C virus-infected patients with and without mixed cryoglobulinaemiaInsights into the Pathobiology of Hepatitis C Virus-Associated CirrhosisHepatitis C Virus (HCV)-Specific CD8+ Cells Produce Transforming Growth Factor That Can Suppress HCV-Specific T-Cell ResponsesTransfection of single-stranded hepatitis A virus RNA activates MHC class I pathwaySimultaneous evaluation of lymphocyte subpopulations in the liver and in peripheral blood mononuclear cells of HCV-infected patients: relationship with histological lesionsInhibition of Natural Killer Cells through Engagement of CD81 by the Major Hepatitis C Virus Envelope ProteinIn Vitro Resistance Study of AG-021541, a Novel Nonnucleoside Inhibitor of the Hepatitis C Virus RNA-Dependent RNA PolymeraseCell Surface Expression of Major Histocompatibility Complex Class I Molecules Is Reduced in Hepatitis C Virus Subgenomic Replicon-Expressing CellsPrevalence of HBV and HCV among blood donors in KosovoDeterminants of viral clearance and persistence during acute hepatitis C virus infectionCourse and outcome of hepatitis CIncreased Fas ligand expression of CD4+ T cells by HCV core induces T cell-dependent hepatic inflammation.Virus-specific CD8(+) T cells with type 1 or type 2 cytokine profile are related to different disease activity in chronic hepatitis C virus infection.Schistosomiasis does not affect the outcome of HCV infection in genotype 4-infected patientsHepatitis C virus reactivation in cancer patients in the era of targeted therapies.Elimination of hepatitis C virus from hepatocytes by a selective activation of therapeutic molecules.Concerted action of the FasL/Fas and perforin/granzyme A and B pathways is mandatory for the development of early viral hepatitis but not for recovery from viral infection.Induction of hepatitis C virus E1 envelope protein-specific immune response can be enhanced by mutation of N-glycosylation sitesA virological perspective on the need for vaccination.Molecular mechanisms involved in the interaction effects of alcohol and hepatitis C virus in liver cirrhosis.Molecular pathogenesis of viral hepatitis.Viral, host and interferon-related factors modulating the effect of interferon therapy for hepatitis C virus infection.Immunopathogenesis of hepatitis C virus in the immunosuppressed host.
P2860
Q24185977-704794B0-8207-4D3F-BE10-C5556F77A987Q24305040-D04CE81F-4BA3-492D-A1AA-4E0C9C7EC5AAQ24338324-FCD3E768-AF9A-4057-A239-44602122061AQ24537657-CFAAA18D-797E-4D5A-B491-9625B296E6A5Q24814428-00EDF5D9-F9CA-40C2-905B-A345D61C2CCDQ27469813-641522AF-EFAB-4C63-AA53-329077BC857CQ27469850-197D53A2-0BAE-4D72-A5C1-4B5D3477ED2BQ27469875-187BD09C-9A13-4199-973A-A50CCC281C20Q27469939-2D38EAB9-F9E7-4507-BE0E-F9B1A759DA89Q27469998-FE7C26F4-56F3-47B0-8218-BD357FD512B9Q27472751-C670E84A-88F4-44BC-AB8B-94B797437918Q27472770-8074B11D-BAAB-4518-9063-584B825775E6Q27472816-3905623D-BEE8-4BBF-AE90-C84FB0E12F75Q27472930-6267C46C-51DE-42FC-A29E-6153851E0759Q27473088-9A4EC134-03AD-4B90-AC8C-B943E487642DQ27477612-2F89C3C0-9CC9-431B-9667-F7BBB8EC3BA3Q27477965-1FF342B8-8F6E-48C3-9E02-A3BFC6CFF2D2Q27478129-5CC3E8AC-763F-4CC0-933E-5270D2CC42AAQ27478238-00FF599B-6BB2-4625-BBBF-B5F161E59511Q27480368-C980466D-D734-439B-9532-9EE03C6FE085Q27480641-95D583F5-68BB-472E-B391-836F8AA859ACQ27480734-333ED64B-5D8B-40CC-AFA8-80D67A585022Q27485143-B4C22538-5974-4068-9755-8CEB8405610DQ27485335-6251B064-6747-407A-8CAE-5AEC854E613AQ27485758-576268ED-5C69-4E82-A9DA-36814A5CC1C3Q27487972-37E2ADF9-788D-480D-B348-7D9D424D8F77Q28131757-D475D241-743B-460C-8625-4DD052E74374Q29620057-90F53419-263F-4DF4-8690-BFE7B2ABCDE6Q30436833-3E0BD509-94F8-4892-B804-8CD9878C739CQ32159849-E94DDD0C-0418-4A7E-9847-FE0E6C051DE3Q33588479-CEBBA55E-E979-4CAA-AFE8-33786E0CE748Q33735212-D6FAACC1-09A3-4D4E-A114-AD6671C6BF99Q33799276-1A2C74CE-B74E-4518-96A3-7AC2CDD465F0Q33854729-75C3FF84-4BBD-4CD4-9E25-D0FFE76EDC12Q33870023-F833DF8C-8D5F-4CAB-A550-A30E2106927FQ33950163-80A50411-EB9A-4574-8B3A-E3F16C49FBDBQ33959178-FAF21856-87CC-4F53-8D27-9A0D159E72C6Q34095695-A1EBF92F-EB96-4065-9DD9-5EB29EAE8A36Q34129547-6DF7C26E-2522-446C-BC32-1724EA7752B8Q34148593-E18FF21A-3943-4D2E-AEF1-00BC17BFCC3D
P2860
Pathogenesis of chronic hepatitis C: immunological features of hepatic injury and viral persistence.
description
1999 nî lūn-bûn
@nan
1999 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Pathogenesis of chronic hepati ...... injury and viral persistence.
@ast
Pathogenesis of chronic hepati ...... injury and viral persistence.
@en
type
label
Pathogenesis of chronic hepati ...... injury and viral persistence.
@ast
Pathogenesis of chronic hepati ...... injury and viral persistence.
@en
prefLabel
Pathogenesis of chronic hepati ...... injury and viral persistence.
@ast
Pathogenesis of chronic hepati ...... injury and viral persistence.
@en
P356
P1433
P1476
Pathogenesis of chronic hepati ...... c injury and viral persistence
@en
P2093
P304
P356
10.1002/HEP.510300312
P407
P577
1999-09-01T00:00:00Z